tiprankstipranks
Trending News
More News >
Capricor Therapeutics (CAPR)
NASDAQ:CAPR

Compare Capricor Therapeutics (CAPR) vs. Competitors

Compare
1,234 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Capricor Therapeutics
$24.79
$1.33B
-13.78
94.89%
8 Buy
0 Hold
0 Sell
Strong Buy
Galectin Therapeutics
$5.71
$203.75M
-5.19
176.58%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alector
$1.92
$200.84M
-1.79
7.26%
1 Buy
5 Hold
2 Sell
Hold
4D Molecular Therapeutics
$7.86
$428.51M
-2.00
65.13%
6 Buy
1 Hold
0 Sell
Strong Buy
Humacyte
$1.11
$218.09M
-4.65
-74.72%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CAPR
Capricor Therapeutics
24.79
11.32
84.04%
GALT
Galectin Therapeutics
3.07
1.79
139.84%
ALEC
Alector
1.92
0.24
14.29%
IMAB
FDMT
4D Molecular Therapeutics
7.86
2.82
55.95%
HUMA
Humacyte
1.11
-3.47
-75.76%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts